Intelligent Relations
Preston by Intelligent Relations
Mohsin Ali
Gray shield icon
Is this you?
Claim your profile.

Mohsin Ali

Director of Communications

AS SEEN ON
footballtoday.com, SAMAA TV, Hackerlap

Preston's Summary

Mohsin Ali is the Director of Communications at his organization. He specializes in themes related to sports, particularly competitive sports and sports business, alongside his interests in engineering, mechanical engineering, and healthcare. Mohsin's work has been featured in notable publications including Wiley, MDPI, The Journal of Clinical Psychiatry, and Hindustan Times Syndication.

Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston

Geo Focus

Coverage Attributes:

Beta
Informative: 66 %
Opinion: 10 %
Data Driven: 10 %
Events: 6 %
Interviews Q&as: 2 %

Themes Covered:

Not enough data icon

Not enough data

Most Recent Topics:

  • Individual Sports
  • Team Sports

Pitching Insights

Mohsin Ali's coverage predominantly focuses on football, specifically event coverage and evolving stories within the sport. Given this focus, he may be most receptive to pitches that provide exclusive insights into upcoming matches, transfer news, or injury updates relating to football teams.

Additionally, Mohsin's inclusion of government announcements suggests a potential interest in regulatory changes impacting sports. Therefore, relevant story angles could include how new regulations might affect players or clubs at an international level.

As his geographic focus is not specified but given the nature of football as a global sport, pitching widely appealing topics such as major team transfers or international competitions could resonate with him.

This information evolves through artificial intelligence and human feedback. Improve this profile .

Journalists With Similar Coverage:

Based on similarity of content.
Sami Mokbel

Sami Mokbel

Sport journalist
*********el@************.uk
Publications
BBC World, BBC News, shango.media, durhamonair.com, 234radio.com
Most recent topics
Not enough data
Red Billy

Red Billy

Managing Editor
******ly@****************.com
Publications
The People Person
Most recent topics
Not enough data
Tom Gott

Tom Gott

Writer, Reporter And Editor
******tt@*******om
Publications
Sports Illustrated, The San Luis Obispo Tribune newspaper, SAMMY A. CAVES, D.M.D., P.C., Merced Sun-Star, The Sacramento Bee
Most recent topics
Not enough data
Kieran Horn

Kieran Horn

Brand Manager
*********rn@**********om
Publications
AOL UK, What The Footie, Manchester Evening News, The Mirror, Daily Express
Most recent topics
Not enough data
Rob McCarthy

Rob McCarthy

**b@*********************g.com
Publications
TeamTalk Group, Sky Broadcasting Ltd., LiveScore, NewsBreak
Most recent topics
Not enough data
Katherine Walsh

Katherine Walsh

Digital Sports Reporter
************lsh@**********.uk
Publications
The Sun, The Irish Sun, The US Sun
Most recent topics
Not enough data

Articles

Edumy center

Beyond the Guidelines: Evaluating BI-RADS 3 Lesions in a High-Suspicion Breast Cancer Population: Outcomes and Clinical Implications

By: Rashid Latif, Mohsin Ali, Shaukat Khanum, Fatima Jinnah

Objective: BI-RADS category 3 lesions are typically benign (<2% malignancy risk), managed with follow-up imaging, but their upgrade to BI-RADS 4 may indicate malignancy, particularly in high-risk patients. This study evaluates malignancy risk and predictors among BI-RADS 3 lesions upgraded to BI-RADS 4 in a cohort with a high prevalence of breast cancer history. Methods: We retrospectively analyzed 352 patients undergoing breast ultrasound from June 2021 to June 2023, with 123 categorized as BI-RADS 3. Of these, 17 patients (18 lesions) were upgraded to BI-RADS 4 and biopsied. Data included age, prior breast cancer history (100/123, 81.3%), lesion characteristics (size, number, morphology), and histopathology. Descriptive statistics, binomial tests, Fisher's exact tests, and logistic regression were used to assess upgrade rates, malignancy rates, and predictors, with significance at p=0.05. Result: The upgrade rate was 13.8% (17/123; 95% CI: 8.5–21.0%), significantly exceeding the ACR's <2% benchmark (p=0.05). Among upgraded lesions, 11.1% (2/18; 95% CI: 1.4–34.7%) were malignant (recurrent breast cancer, lymphomatous lymph node), also surpassing the <2% benchmark (p=0.05). Benign outcomes mainly included stromal fibrosis (38.9%) followed by benign lymphadenopathy (27.8%), and fibroadenoma (22.2%). Lesion size (OR=1.15 per mm, p=0.05) and multiple lesions (OR=3.2, p=0.05) predicted malignancy, while age, cancer history, and morphology were not significant (p>0.05). Conclusion: The high upgrade and malignancy rates in this high-risk cohort suggest that BI-RADS 3 lesions with larger size or multiple foci, particularly in breast cancer survivors, may warrant earlier biopsy to detect malignancy, thereby emphasizing the need for refined surveillance criteria.

© 2026 Intelligent Relations